Advanced search
Publication Cover
Gynecological Endocrinology Volume 37, 2021 - Issue 9
Submit an article Journal homepage
174
Views
1
CrossRef citations to date
0
Altmetric
UNEXPLAINED INFERTILITY

Do follicular fluid advanced glycation end products levels affect the ovarian response in unexplained infertility?

Banu Sevena Department of Obstetrics and Gynecology, University of Health Sciences, Zekai Tahir Burak Women Health Care, Training and Research Hospital, Ankara, TurkeyCorrespondence[email protected]
,
Yasemin Tascıa Department of Obstetrics and Gynecology, University of Health Sciences, Zekai Tahir Burak Women Health Care, Training and Research Hospital, Ankara, Turkey
,
Cavidan Gülermana Department of Obstetrics and Gynecology, University of Health Sciences, Zekai Tahir Burak Women Health Care, Training and Research Hospital, Ankara, TurkeyORCID Iconhttps://orcid.org/0000-0003-4960-991X
ORCID Icon,
Tuba Candarc Department of Medical Biochemistry, Faculty of Medicine, Ufuk University, Ankara, Turkey
,
Kuntay Kokanalıa Department of Obstetrics and Gynecology, University of Health Sciences, Zekai Tahir Burak Women Health Care, Training and Research Hospital, Ankara, Turkey
,
Yasemin Yükselb Department of Embryology, University of Health Sciences, Zekai Tahir Burak Women Health Care, Training and Research Hospital, Ankara, Turkey
,
Yesim Bardakcıb Department of Embryology, University of Health Sciences, Zekai Tahir Burak Women Health Care, Training and Research Hospital, Ankara, Turkey
&
Yaprak Engin-Ustüna Department of Obstetrics and Gynecology, University of Health Sciences, Zekai Tahir Burak Women Health Care, Training and Research Hospital, Ankara, Turkey
 show all
Pages 802-806 | Received 14 Oct 2020, Accepted 25 Feb 2021, Published online: 16 Mar 2021

References

  • Dumesic DA, Meldrum DR, Katz-Jaffe MG, et al. Oocyte environment: follicular fluid and cumulus cells are critical for oocyte health. Fertil Steril. 2015;103(2):303–316.
  • Wang B, Hao M, Yang Q, et al. Follicular fluid soluble receptor for advanced glycation endproducts (sRAGE): a potential protective role in polycystic ovary syndrome. J Assist Reprod Genet. 2016;33(7):959–965.
  • Fujii EY, Nakayama M. The measurements of RAGE, VEGF, and AGEs in the plasma and follicular fluid of reproductive women: the influence of aging. Fertil Steril. 2010;94(2):694–700.
  • Thomas MC, Baynes JW, Thorpe SR, et al. The role of AGEs and AGE inhibitors in diabetic cardiovascular disease. Curr Drug Targets. 2005;6(4):453–474.
  • Takeuchi M. Serum levels of toxic AGEs (TAGE) may be a promising novel biomarker for the onset/progression of lifestyle-related diseases. Diagnostics (Basel). 2016;6(2):23.
  • Yamagishi S, Nakamura K, Imaizumi T. Advanced glycation end products (AGEs) and diabetic vascular complications. Curr Diabetes Rev. 2005;1(1):93–106.
  • Diamanti-Kandarakis E, Piperi C, Korkolopoulou P, et al. Accumulation of dietary glycotoxins in the reproductive system of normal female rats. J Mol Med. 2007;85(12):1413–1420.
  • Singh R, Barden A, Mori T, et al. Advanced glycation end-products: a review. Diabetologia. 2001;44(2):129–146.
  • Tatone C, Amicarelli F, Carbone MC, et al. Cellular and molecular aspects of ovarian follicle ageing. Hum Reprod Update. 2008;14(2):131–142.
  • Yao Q, Liang Y, Shao Y, et al. Advanced glycation end product concentrations in follicular fluid of women undergoing IVF/ICSI with a GnRH agonist protocol. Reprod Biomed Online. 2018;36(1):20–25.
  • Alviggi C, Andersen CY, Buehler K, Poseidon Group (Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number), et al. A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept. Fertil Steril. 2016;105(6):1452–1453.
  • Sunkara SK, Rittenberg V, Raine-Fenning N, et al. Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles. Hum Reprod. 2011;26(7):1768–1774.
  • Steward RG, Lan L, Shah AA, et al. Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles. Fertil Steril. 2014;101(4):967–973.
  • Diamanti-Kandarakis E, Piperi C, Patsouris E, et al. Immunohistochemical localization of advanced glycation end-products (AGEs) and their receptor (RAGE) in polycystic and normal ovaries. Histochem Cell Biol. 2007;127(6):581–589.
  • Law YJ, Zhang N, Venetis CA, et al. The number of oocytes associated with maximum cumulative live birth rates per aspiration depends on female age: a population study of 221 221 treatment cycles. Hum Reprod. 2019;34(9):1778–1787.
  • Tantalaki E, Piperi C, Livadas S, et al. Impact of dietary modification of advanced glycation end products (AGEs) on the hormonal and metabolic profile of women with polycystic ovary syndrome (PCOS). Hormones (Athens). 2014;13(1):65–73.
  • Nunez-Calonge R, Cortes S, Gutierrez Gonzalez LM, et al. Oxidative stress in follicular fluid of young women with low response compared with fertile oocyte donors. Reprod Biomed Online. 2016;32(4):446–456.
  • Pertynska-Marczewska M, Diamanti-Kandarakis E. Aging ovary and the role for advanced glycation end products. Menopause. 2017;24(3):345–351.
  • de Bruin JP, Dorland M, Spek ER, et al. Age-related changes in the ultrastructure of the resting follicle pool in human ovaries. Biol Reprod. 2004;70(2):419–424.
  • Wang BJ, Qian L, Li J, et al. sRAGE plays a role as a protective factor in the development of PCOS by inhibiting inflammation. Gynecol Endocrinol. 2020;36(2):148–151.
  • Bonetti TC, Borges E, Jr., Braga DP, et al. Intrafollicular soluble receptor for advanced glycation end products (sRAGE) and embryo quality in assisted reproduction. Reprod Biomed Online. 2013;26(1):62–67.
  • Jinno M, Takeuchi M, Watanabe A, et al. Advanced glycation end-products accumulation compromises embryonic development and achievement of pregnancy by assisted reproductive technology. Hum Reprod. 2011;26(3):604–610.
  • Polyzos NP, Devroey P. A systematic review of randomized trials for the treatment of poor ovarian responders: is there any light at the end of the tunnel? Fertil Steril. 2011;96(5):1058–1061 e7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.